Author :   Zhylchuk V.E.

CLINICAL EFFECTIVENESS OF ERBISOL^® ULTRAPHARM IN COMPLEX TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER

Authors:Maksymiak G.I. Shcheglovska T.D. Nikolayenko A.N. Коrnilina Е.М. ... №23 4 2021 148

MODIFICATION OF EPITHELIAL-MESENCHYMAL TRANSITION IN BREAST CANCER CELLS BY MEANS OF THEIR CO-CULTIVATION WITH FIBROBLASTS AND BONE MARROW CELLS

Authors:Bezdenezhnykh N.O. Semesiuk N.I. Lykhova O.O. Zhylchuk V.E. ... №15 3 2013 4

THE EXPRESSION OF MARKERS OF EPITHELIAL-MESENCHYMAL TRANSITION AND DRUG RESISTANCE PROTEINS AS A PROGNOSTIC INDICATOR IN PATIENTS WITH COLORECTAL CANCER

Authors:Bezdieniezhnykh N.O. Zhylchuk V.E. Glanko M.V. Adamenko I.M. ... №18 1 2016 9

MICROENVIRONMENT OF TUMOR CELLS AS A SOURCE OF MODIFIERS OF EPITHELIAL-MESENCHYMAL TRANSITION AND TARGET FOR PERSONALIZED ANTICANCER THERAPY

Authors:Kudryavets Yu.I. Bezdieniezhnykh N.O. Semesyuk N.I. Zhylchuk A.V. ... №18 4 2016 3

CHOOSING CHEMOTHERAPEUTIC TREATMENT USING THE SENSITIVITY MARKERS IN PATIENTS WITH COLORECTAL CANCER

Authors:Glyanko M.V. Zhylchuk A.V. Zhylchuk V.E. Maksymiak Yu.I. Kudryavets,G.I. №19 2 2017 13

APPLICATION OF ERBISOL® ULTRAPHARM FOR THE TREATMENT OF PATIENTS WITH PANCREATIC CANCER

Authors:Maksymiak G.I. Zhylchuk V.E. Zhylchuk A.V. Kudryavets Yu.I. ... №21 1 2019 20

CLINICAL ASPECTS OF DRUG CLASS «ERBISOL®» IN THE TREATMENT OF SOLID TUMORS

Authors:Maksymiak G.I. Chyshkevich Yu.V. Smirnov G.Yu. Mylashin O.B. ... №12 3 2010 294